E
EGBOT
Guest
Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis
Source: Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis
HTML:
Anika Therapeutics, Inc.,, a leader in products for tissue protection, healing, and repair based on hyaluronic acid technology, today reported positive results from the CINGAL 13-02 study evaluating the safety of a repeat injection of Cingal for symptomatic relief of osteoarthritis of the knee.
Source: Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis